To ask Her Majesty's Government what financial support they have provided to companies, institutions, and any other organisations, in the UK which are engaged in the development of a COVID-19 vaccine.
Answered on
28 April 2020
On 21 April 2020, the Government announced a total of £42.5 million to support clinical trials for the vaccines being developed at the University of Oxford and Imperial College London. This funding is in addition to the £4.7 million previously granted to the University of Oxford, Imperial College London and Public Health England for vaccine research through the joint UK Research and Innovation – Medical Research Council and the Department, via the National Institute for Health Research ‘Covid-19 Rapid Response Research Call’. This follows the Government’s £250 million pledge to develop a vaccine, and announcement of a new Vaccines Taskforce, putting the United Kingdom at the forefront of international efforts to fight the virus.